VASOGNOSIS, INC.

MILWAUKEE, WI · Founded 2019 · Medtech · Private

AI software using convolutional neural networks to identify and analyze brain aneurysms in MRI/CT images for clinical decision support

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
MILWAUKEE, WI
Founded
2019
Latest Form D
$850K offered, Sep 2020
Total capital
$1.1M
Federal grants
$225K
1 award · 2020
Rank in peer group#30 of 50
Private capital raised
$850K
1 Form D · last Sep 2020
73 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2020FEDERAL ↑EQUITY ↓Cumulative $1.1M$225K1st Form D$850K
2020FEDERAL ↑EQUITY ↓Cumulative $1.1M$225K1st Form D$850K

Latest events

  • Offering registeredForm D · SEC · 1st filing$850K
  • Federal grantNSF · Phase I · STTR Phase I: Development and Validation of Noninvasive High-Fidelity Serial Aneurysm Diagnostic Software$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

1month

from VASOGNOSIS, INC.’s first federal award to its first private round.

First federal award · Aug 2020
NSF · $225K
First Form D · Sep 2020
$850K · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 50 peers

Line = median

Medtech · Software

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Ali BakhshinejadResearcherExecutive Officer, DirectorLinked by $225K in grants as PI

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Cambre KellySimilar federal contract value in Medtech · null in contracts
  • InnovasonicSimilar federal contract value in Medtech · null in contracts
  • Elidah, Inc.Similar federal contract value in Medtech · null in contracts
  • ZEBRA ANALYTIX, INC.Similar federal contract value in Medtech · null in contracts
  • ANALYTICAL DIAGNOSTIC SOLUTIONS INCSimilar federal contract value in Medtech · null in contracts
  • COLABS, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .